Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins
Auditory hallucinations – or hearing voices that others do not hear – affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.
Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins
Auditory hallucinations—or hearing voices that others do not hear—affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience ...
Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins
Auditory hallucinations—or hearing voices that others do not hear—affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience ...
Researchers test noninvasive ultrasound treatment for schizophrenia-related hallucinations
Auditory hallucinations – or hearing voices that others do not hear – affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations.
last updated on 3 Nov 11:54